Every Form 4 that Calumet, Inc. (CLMT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CLMT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLMT filings page.
Lunin David reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. executive vice president and CFO David Lunin reported receiving two grants of restricted stock units, totaling 9,786 and 7,080 units. Each unit equals one share of common stock. The 2025 performance-based units remain subject to service vesting through February 25, 2028, and the additional units vest on February 24, 2029.
Morical Gregory J reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. reported that SVP and General Counsel Gregory J. Morical received equity awards in the form of stock units. On February 24, 2026, he was granted 6,197 Restricted Stock Units and 4,432 Common Stock Units, each economically equivalent to one share of Calumet common stock.
Some of these awards are 2025 performance-based restricted stock units, with performance certified by the board on the grant date and additional service-based vesting required through February 25, 2028. Other Restricted Stock Units are scheduled to vest on February 24, 2029, tying a portion of his compensation to longer-term company performance and continued service.
Fleming Bruce A reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. executive Bruce A. Fleming, EVP – Montana Renewables, reported receiving two equity awards of restricted stock units. He was granted 10,850 performance-based restricted stock units tied to 2025 performance that now remain subject to service-based vesting through February 25, 2028, and a separate grant of 7,700 restricted stock units that vest on February 24, 2029. Each unit represents the economic equivalent of one share of Calumet, Inc. common stock and was awarded at no cash purchase price.
Obermeier Scott reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. granted Executive Vice President – Specialties Scott Obermeier a total of 17,392 restricted stock units, each equivalent to one share of Calumet common stock.
Of these, 9,654 units are 2025 performance-based awards that remain subject to service-based vesting through February 25, 2028, and 7,738 additional units vest on February 24, 2029.
Borgmann Louis Todd reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. reported that Chief Executive Officer Louis Todd Borgmann received awards of restricted stock units. He was granted 67,882 performance-based restricted stock units tied to 2025 performance, which the board certified on the grant date, and these remain subject to continued service-based vesting through February 25, 2028. He also received a separate grant of 64,102 restricted stock units that vest on February 24, 2029. Each restricted stock unit represents the economic equivalent of one share of Calumet common stock, and the awards were recorded at no cash purchase price.
Calumet, Inc. reported that one of its directors acquired 5,053 shares of common stock, par value $0.01 per share, on 12/04/2025 through the settlement of restricted stock units at a price of $0 per share.
After this transaction, the director directly beneficially owned 24,733 shares of Calumet common stock. The related derivative position of 5,053 restricted stock units was reduced to zero as they were fully converted into common stock, with each unit economically equivalent to one share and 100% vested.
Calumet, Inc. reported an insider equity transaction by one of its directors.
On December 4, 2025, the director converted 2,526 restricted stock units into common stock and disposed of 1,011 common shares. After these transactions, the director beneficially owns 28,793 shares of Calumet common stock directly. Each restricted stock unit is the economic equivalent of one Calumet common share, is 100% vested, and can be settled in shares or their cash value. The director elected to have 40% of the vested restricted stock units settled in the cash equivalent of a common share.
Calumet (CLMT) reported a Form 4 for a director showing awards of restricted stock units on 11/06/2025. The filing lists 1,281 RSUs (Transaction Code A) at a price of $0 and 427 RSUs (Code A) at a price of $0, both recorded as direct ownership.
The 1,281 RSUs are 100% vested and settle upon the earlier of a specified date or the reporting person’s termination. The 427 RSUs settle under the Deferred Compensation Plan and vest 25% on July 1 of each year beginning July 1, 2026.
Calumet, Inc. (CLMT) reported a director’s equity award activity. On November 6, 2025, the reporting person acquired 384 Restricted Stock Units (RSUs) and 128 RSUs at $0 per unit, reported as direct ownership.
Each RSU equals one share of Calumet common stock. The 384 RSUs are 100% vested and will be settled upon the earlier of a date specified by the reporting person or the reporting person’s termination date. The 128 RSUs, granted under the Deferred Compensation Plan, will be settled upon the earlier of a specified date or termination, with 25% vesting each July 1 beginning July 1, 2026.
Calumet, Inc. (CLMT) disclosed a Form 4 showing a director received two Restricted Stock Unit awards on 11/06/2025. The filings list 1,761 RSUs (100% vested, to be settled upon the earlier of a specified date or termination) and 587 RSUs (under the Deferred Compensation Plan, vesting 25% each July 1 beginning July 1, 2026). Both derivative positions are shown as Direct (D) ownership at a price of $0 per unit.
Calumet, Inc. (CLMT) reported a routine insider equity event. A director filed a Form 4 showing two grants of restricted stock units on 11/06/2025: 1,172 RSUs and 390 RSUs, each acquired at $0 and held directly. Each RSU represents the economic equivalent of one share of Calumet common stock.
The filing notes distinct settlement and vesting terms. The 1,172 RSUs are 100% vested and settle upon the earlier of a date specified by the reporting person or their termination date. The 390 RSUs, granted under a Deferred Compensation Plan, settle on the same trigger, with 25% vesting on July 1 of each year beginning July 1, 2026.